Fast-growing Bristol digital transformation specialist Amdaris has appointed Dawood Khan to the role of sales director in a move it says will broaden its offering will support its continued expansion. Dawood, pictured, has joined Amdaris – which has grown 40% year on year for the past four years –...
The South West continues to be the best place in the UK for gender equality at work, according to research by accountancy group PwC. The firm’s latest annual Women in Work Index places the region in the top spot for the second year in a row. It has also extended...
A Bristol-headquartered pre-school education group with sites across the South West and Wales has expanded its presence in Wiltshire with the acquisition of two day nurseries. Westbury on Trym-based BBN bought the New Road Nursery in Chippenham and Little Robins in Melksham for an undisclosed sum from their longstanding...
Global accountancy group KPMG has combined the top jobs in its Bristol and Plymouth offices, with Ian Brokenshire, currently senior partner in Plymouth, taking up the role next week. Ian, pictured right, replaces Andrew Hodgson, pictured below, who returns to a full time mergers and acquisition (M&A) advisory role...
A new fund to support start-ups across the South West has been launched by a group of successful Bristol-based entrepreneurs. BPEC Seed is seeking investment opportunities among early-stage, scalable and innovative firms with credible teams and clear marketing opportunity. It has already made its first – so far unnamed...
Financial and professional services firm Smith & Williamson has appointed Andrew Manning as a partner in Bristol to lead its new risk advisory business. Andrew, pictured, has more than 20 years’ professional services experience leading on risk assurance and controls transformation and has worked across a range of clients...
New cell therapies to treat solid tumours in cancer patients are to be developed by Bristol firm CytoSeek after it raised £3.5m from city-based Science Creates Ventures. The seed funding is the first investment by Science Creates Ventures (SCV), since it was set up last year as Bristol’s ‘deep...
Bristol financial planning firm Paradigm Norton has made a double acquisition in a move that has expanded its presence in the South West and London. Paradigm Norton, which provides financial planning, investment portfolio management and tax and estates services to clients already primarily based in Greater London and the...
Many businesses across the West of England are facing uncertainty and challenges that could not have been foreseen a year ago when the pandemic hit our economy and livelihoods. With our new relationship with Europe, we also know that doing business with Europe has changed. This has meant adapting...
Accountancy group Deloitte’s Bristol-based mergers and acquisitions (M&A) team has completed five deals in just five weeks, including a successful refinancing of iconic Somerset shoe brand Clarks. The South & Wales team worked with private companies and private equity houses on the deals, which span the consumer products, industrial...
National accountancy firm Smith & Williamson is launching a series of webinars for partners in professional practices later this month. The series begins on Thursday, March 25, with ‘Introduction to the Partnership,’ which will guide newly appointed equity partners through the transition from employee to equity partner. This will...
Bosses at fast-growing Bristol fintech innovator Parmenion are looking ahead to further expansion following its £102m sale this week by Standard Life Aberdeen to a private equity firm. London-based Preservation Capital Partners (PCP) said it would back Parmenion’s management team in their expansion ambitions. Parmenion, which has developed market-leading discretionary...
A dedicated cell and gene therapy centre is to be set up in Bristol by city-based bio-pharmaceutical consultancy eXmoor in a move that will increase its staffing from 40 to around 200. In a major boost for Bristol’s emerging biotech sector, the 50,000 sq ft cell and gene therapy...
